Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Rescuing Damaged Neurons in Parkinson’s Disease
Disease Discoveries

Rescuing Damaged Neurons in Parkinson’s Disease

By Nora DunneMar 14, 2016
Share
Facebook Twitter Email
α-syn in PD
Immunostaining of α-synuclein (red) in Parkinson’s disease neurons at day 330 shows that rab1a reduces α-synuclein within cell bodies.

Northwestern Medicine scientists have shed light on a hallmark of Parkinson’s disease that has been poorly understood up until now, the buildup of a protein called α-synuclein in the brain.

In a study published in Proceedings of the National Academy of Sciences (PNAS), they revealed a pathway for potential future therapies to treat the incurable neurodegenerative disease and disorders related to it. Currently, physicians are able to treat only the symptoms of Parkinson’s disease, because there are no disease-altering therapies available.

“What happens after α-synuclein starts accumulating? Why is it causing dysfunction of human neurons, and how can we prevent this dysfunction early in the disease process? This paper addresses these important questions,” said the study’s principal investigator Dimitri Krainc, MD, PhD, Aaron Montgomery Ward Professor and chair of Neurology.

Krainc and first author Joseph Mazzulli, PhD, assistant professor of Neurology, showed in the study that too much α-synuclein reduces the capacity of lysosomes, recycling factories in cells that remove cellular debris. The scientists found that this impairment occurs because enzymes in lysosomes called hydrolases, which digest that debris, are disrupted.

“Hydrolases have to be transported into the lysosome from the endoplasmic reticulum, and that transport is tightly regulated,” Krainc explained. “This trafficking is what the α-synuclein impairs. When these enzymes don’t make it to lysosomes, lysosomes can’t do their job.”

Using neurons acquired from patients with Parkinson’s disease by reprogramming their skin cells, the scientists demonstrated multiple strategies to restore hydrolase trafficking and thus improve lysosome function. These strategies included knocking down α-synuclein and overexpressing the protein rab1a, which is also involved in hydrolase transport.

By culturing human neurons over hundreds of days, the scientists were able to monitor the lysosomal system as the cells aged.

Krainc_dimitri2.jpg
Dimitri Krainc, MD, Aaron Montgomery Ward Professor and chair of Neurology, led a study that reveals a potential new therapeutic pathway for treating Parkinson’s disease.

“We realized that this trafficking defect is an early event in the disease, and if we reverse it we can rescue these neurons from degenerating,” Krainc said. “Targeting this really critical downstream effect of accumulated α-synuclein may have therapeutic value. We are exploring this by developing small molecules as potential therapeutics.”

In another recent paper, published and featured in the Journal of Neuroscience, Krainc’s lab continued to illuminate the pathology of Parkinson’s disease. The scientists showed that mutations in the parkin gene – responsible for inherited forms of the disease – disrupt lysosomal trafficking pathways by reducing the function of the protein rab7.

“Studies of rare genetic forms of Parkinson’s disease such as parkin provide important insights and specific therapeutic targets for more common sporadic forms the disease,” Krainc said.

This research was supported by the National Institute of Neurological Disorders and Stroke grants R01NS076054, R01NS092823 and U24NS078338.

Neurology and Neuroscience Research
Share. Facebook Twitter Email

Related Posts

Hospitals Bound to Patient Safety Rules that Aren’t all Backed by Evidence

Jun 24, 2022

Identifying Protein Interactions that Promote Cancer Growth

Jun 24, 2022

Calcium Channel Blockers May Improve Chemotherapy Response

Jun 21, 2022

Comments are closed.

Latest News

Hospitals Bound to Patient Safety Rules that Aren’t all Backed by Evidence

Jun 24, 2022

Identifying Protein Interactions that Promote Cancer Growth

Jun 24, 2022

Combination Treatment May Improve Quality of Life in Kidney Cancer

Jun 23, 2022

Calcium Channel Blockers May Improve Chemotherapy Response

Jun 21, 2022

Expanded Role for Calcium Channels in T-Cells

Jun 17, 2022
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20220607_Feinberg Campus_0070
20220607_Feinberg Campus_0066
20220607_Feinberg Campus_0054
Northwestern University 2022. Photo by Jim Prisching
20220607_Feinberg Campus_0077
20220607_Feinberg Campus_0063
20220607_Feinberg Campus_0111
20220607_Feinberg Campus_0083
20220607_Feinberg Campus_0018
20220607_Feinberg Campus_0023
20220607_Feinberg Campus_0072 (2)
20220607_Feinberg Campus_0120

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2022 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.